3/ Cognitive enhancement, and reversal of neurodegenerative disease

Long-term methylene blue treatment in mouse models of Alzheimer's and Parkinson's disease has shown promise, not only by reducing pathological protein aggregates (Aβ plaques and phospho-tau tangles) but also by